<?xml version="1.0"?>
<?xml-stylesheet type='text/xsl' href='../../ld2.xsl'?>
<LOBBYINGDISCLOSURE2>
   <imported>N</imported>
   <pages>3</pages>
   <submitURL></submitURL>
   <organizationName>Joel R. Junker &amp; Associates</organizationName>
   <prefix></prefix>
   <firstName></firstName>
   <lastName></lastName>
   <registrantDifferentAddress>N</registrantDifferentAddress>
   <address1>1191 Second Ave., Ste. 1800</address1>
   <address2></address2>
   <city>Seattle</city>
   <state>WA</state>
   <zip>98101</zip>
   <zipext></zipext>
   <country>USA</country>
   <principal_city></principal_city>
   <principal_state></principal_state>
   <principal_zip></principal_zip>
   <principal_zipext></principal_zipext>
   <principal_country></principal_country>
   <selfSelect>N</selfSelect>
   <clientName>Nufarm Americas, Inc.</clientName>
   <clientGovtEntity>N</clientGovtEntity>
   <senateID>323956-12</senateID>
   <houseID>399400000</houseID>
   <reportYear>2013</reportYear>
   <reportType>Q1</reportType>
   <terminationDate></terminationDate>
   <noLobbying></noLobbying>
   <income></income>
   <expenses></expenses>
   <expensesMethod></expensesMethod>
   <printedName>Joel R. Junker</printedName>
   <signedDate>04/02/2013</signedDate>
   <alis>
      <ali_info>
         <issueAreaCode>TAR</issueAreaCode>
         <specific_issues>
            <description>Joel R. Junker &amp; Associates is retained by Nufarm Americas, Inc. to facilitate the passage of duty suspension bills HR5346 (Imazapyr) &amp; 5347 (metsulfuron-methyl) and the extension of duty suspension bills HR 5337 (Triphenylytin Hydroxide), 5338 (4-(2, 4-dichlorophenoxuyl) butyric acid (CAS NO. 94-82-6) and 4-(2, 4 dichlorophenoxyl) butyric acid, dimenthylamine salt), 5339 (Bromoxynil Octonoate), 5440 (dichloroprop-p acid, dichlorprop-p dimenthylamine salt, and dichlorprop-p 2-ethylhexyl ester), </description>
            <description>5341 (Givverellic Acid), 5432 (2-methyl-4-chlorophenoxyacetic acid), 5433 (2-ethylhexyl (4-chloro-2-methylphenoxy) acetate), 5434 (2-Methyl-4-chlorophenoxyacetic acid, dimethylene salt) and 5345 (MCPB Acid and MCPB Sodium Salt). </description>
         </specific_issues>
         <federal_agencies>U.S. HOUSE OF REPRESENTATIVES</federal_agencies>
         <lobbyists>
            <lobbyist>
               <lobbyistFirstName>Joel</lobbyistFirstName>
               <lobbyistLastName>Junker</lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
            <lobbyist>
               <lobbyistFirstName></lobbyistFirstName>
               <lobbyistLastName></lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
            <lobbyist>
               <lobbyistFirstName></lobbyistFirstName>
               <lobbyistLastName></lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
            <lobbyist>
               <lobbyistFirstName></lobbyistFirstName>
               <lobbyistLastName></lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
            <lobbyist>
               <lobbyistFirstName></lobbyistFirstName>
               <lobbyistLastName></lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
            <lobbyist>
               <lobbyistFirstName></lobbyistFirstName>
               <lobbyistLastName></lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
            <lobbyist>
               <lobbyistFirstName></lobbyistFirstName>
               <lobbyistLastName></lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
            <lobbyist>
               <lobbyistFirstName></lobbyistFirstName>
               <lobbyistLastName></lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
            <lobbyist>
               <lobbyistFirstName></lobbyistFirstName>
               <lobbyistLastName></lobbyistLastName>
               <lobbyistSuffix></lobbyistSuffix>
               <coveredPosition></coveredPosition>
               <lobbyistNew>N</lobbyistNew>
            </lobbyist>
         </lobbyists>
         <foreign_entity_issues>Nufarm Limited, an Australian company, has an interst in the lobbying activity of Nufarm Americas, Inc. in that Nufarm Americas, Inc. is a wholly owned subsidiary. </foreign_entity_issues>
      </ali_info>
   </alis>
   <updates>
      <clientAddress></clientAddress>
      <clientCity></clientCity>
      <clientState></clientState>
      <clientZip></clientZip>
      <clientZipext></clientZipext>
      <clientCountry></clientCountry>
      <prinClientCity></prinClientCity>
      <prinClientState></prinClientState>
      <prinClientZip></prinClientZip>
      <prinClientZipext></prinClientZipext>
      <prinClientCountry></prinClientCountry>
      <generalDescription></generalDescription>
      <inactive_lobbyists>
         <inactive_lobbyist>
            <firstName></firstName>
            <lastName></lastName>
            <suffix></suffix>
         </inactive_lobbyist>
         <inactive_lobbyist>
            <firstName></firstName>
            <lastName></lastName>
            <suffix></suffix>
         </inactive_lobbyist>
         <inactive_lobbyist>
            <firstName></firstName>
            <lastName></lastName>
            <suffix></suffix>
         </inactive_lobbyist>
         <inactive_lobbyist>
            <firstName></firstName>
            <lastName></lastName>
            <suffix></suffix>
         </inactive_lobbyist>
      </inactive_lobbyists>
      <inactive_ALIs>
         <ali_Code></ali_Code>
         <ali_Code></ali_Code>
         <ali_Code></ali_Code>
         <ali_Code></ali_Code>
         <ali_Code></ali_Code>
         <ali_Code></ali_Code>
         <ali_Code></ali_Code>
         <ali_Code></ali_Code>
         <ali_Code></ali_Code>
      </inactive_ALIs>
      <affiliatedUrl></affiliatedUrl>
      <affiliatedOrgs>
         <affiliatedOrg>
            <affiliatedOrgName></affiliatedOrgName>
            <affiliatedOrgAddress></affiliatedOrgAddress>
            <affiliatedOrgCity></affiliatedOrgCity>
            <affiliatedOrgState></affiliatedOrgState>
            <affiliatedOrgZip></affiliatedOrgZip>
            <affiliatedOrgCountry></affiliatedOrgCountry>
            <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
            <affiliatedPrinOrgState></affiliatedPrinOrgState>
            <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
         </affiliatedOrg>
         <affiliatedOrg>
            <affiliatedOrgName></affiliatedOrgName>
            <affiliatedOrgAddress></affiliatedOrgAddress>
            <affiliatedOrgCity></affiliatedOrgCity>
            <affiliatedOrgState></affiliatedOrgState>
            <affiliatedOrgZip></affiliatedOrgZip>
            <affiliatedOrgCountry></affiliatedOrgCountry>
            <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
            <affiliatedPrinOrgState></affiliatedPrinOrgState>
            <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
         </affiliatedOrg>
      </affiliatedOrgs>
      <inactiveOrgs>
         <inactiveOrgName></inactiveOrgName>
         <inactiveOrgName></inactiveOrgName>
         <inactiveOrgName></inactiveOrgName>
      </inactiveOrgs>
      <foreignEntities>
         <foreignEntity>
            <name></name>
            <address></address>
            <city></city>
            <state></state>
            <country></country>
            <prinCity></prinCity>
            <prinState></prinState>
            <prinCountry></prinCountry>
            <contribution></contribution>
            <ownership_Percentage></ownership_Percentage>
         </foreignEntity>
      </foreignEntities>
      <inactive_ForeignEntities>
         <inactive_ForeignEntity></inactive_ForeignEntity>
         <inactive_ForeignEntity></inactive_ForeignEntity>
         <inactive_ForeignEntity></inactive_ForeignEntity>
         <inactive_ForeignEntity></inactive_ForeignEntity>
         <inactive_ForeignEntity></inactive_ForeignEntity>
         <inactive_ForeignEntity></inactive_ForeignEntity>
      </inactive_ForeignEntities>
   </updates>
</LOBBYINGDISCLOSURE2>